Skip to main content
Advanced Technical IVT

neural target engagement

Demonstration that an investigational treatment modulates its intended neurobiological mechanism in the human brain.

Full Definition

Neural target engagement refers to evidence that an investigational psychiatric treatment successfully modulates its intended neurobiological target or pathway in the human brain. This concept bridges preclinical mechanisms with clinical outcomes, providing biological validation that the treatment is working through its hypothesized mechanism of action. In psychiatric drug development, target engagement can be demonstrated through various biomarker approaches including neuroimaging (PET, fMRI), neurophysiology (EEG), or biochemical measures (CSF, blood). Demonstrating target engagement is increasingly important for regulatory agencies and helps optimize dosing, timing, and patient selection for psychiatric interventions.

Usage

Usage note: Hyphenate when used as compound modifier: 'neural-target-engagement biomarker'.

In Context

  • "PET imaging confirmed neural target engagement with 80% receptor occupancy at therapeutic doses." — Phase I study report
  • "The biomarker strategy aimed to demonstrate neural target engagement before proceeding to efficacy studies." — Development plan

Also known as

target modulation mechanism engagement

Contrasted with

off-target effects

Don't confuse with

target selectivity receptor occupancy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON